The effect of detoxification therapy on the ocular fundus state in alcoholic toxic neuroretinopathy
DOI:
https://doi.org/10.31288/oftalmolzh201434146Keywords:
alcoholic toxic neuroretinopathy, biomicroophthalmoscopy, PolyoxidoniumAbstract
Introduction. The changes of the ocular fundus state in alcoholic toxic neuro-retinopathy (ATN) correspond to the stages of the optic nerve edema (Zhaboyedov G. D., 1992): hyperemia, swelling, ischemia and glial atrophy.
Purpose. To study the dynamics of the fundus state of patients at different stages of ATN under the influence of detoxification therapy using polyoxidonium.
Material and methods. The biomicroophthalmoscopy of 158 patients with ATN was conducted before treatment, after treatment and in 1 month after treatment. Group 1 — conventional treatment, group 2 received Polyoxidonium in addition.
Results. In group 1 deterioration of fundus in 1 month after treatment was observed: recurrence of macular edema (ME) in 31,82 % cases at the stage of swelling, the appearance of macula degeneration at the stage of dystrophy with doppler signs of arterio-venous shunt in the superior orbital vein. In group 2 at the stage of swelling more rapid resorption of macula hemorrhages and more often complete disappearance of ME were observed; at the stage of dystrophy there was ME regression, which was not observed in group 1; the deterioration of the fundus in 1 month after treatment was not observed.
Conclusions. The complex detoxification therapy using polyoxidonium resulted in the increase in effectiveness of treatment according to the state of the fundus at the stages of swelling and dystrophy of ATN.
References
1.Gusova MK. Toxic damage of the optic nerve in alcohol in-toxication: thesis for Candidate of Med. Science: 14.00.08. Eye Diseases. Moscow, 2008. 116 p.
2.Egorov EA, Stavitskaia TV, Tutaieva ES. Ophthalmic man-ifestations of general diseases. M.:GEOTAR-Media; 2006. 592 p.
3.Zhaboyedov GD, Skripnik RL. Optic nerve damage. Kyiv: Zdorovia; 2006. 472 p.
4.Kushnir EA. On the possibility of using immunomodulators to correct alcohol motivation: thesis for Candidate of Med. Science: 03.00.13/ Physiology. Moscow, 2005. 169 p.
5.Petrunya AM, Dyakonova TV, Skalyga IM. Evaluating the effectiveness of Glutargin in complex therapy of degenera¬tive diseases of the retina and the optic nerve in patients with chronic alcoholism. Available at: www.health-ua. com/articles/512.html • 19.02.2004
6.Petrunya AM, Skalyga IM. Visual organ damage in patients who abuse alcohol. Oftalmol Zh. 1995; 1:63. Russian.
7.Skripnichenko ZM. On the deleterious effects of alcohol on visual organ. Vestn Oftalmol. 1987; 103(3):73- 6. Russian.
8.Tseunov AV, Valkova IV. On the state of the organ of vision in chronic alcoholism. Vestn Oftalmol. 1987;103(6):34-5.Russian.
9.Dobbs MR. Clinical Neurotoxicology: Syndromes, Sub¬stances, Environments. USA, Philadelphia: Saunders, Elsevier Inc. 2010. 720 p.
10.Sharma P, Sharma R. Toxic optic neuropathy. Indian J Ophthalmol. 2011;59(2):137-41.https://doi.org/10.4103/0301-4738.77035
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 О. В. Недзвецька, Д. О. Петрушенко
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
